BLI-1007

N/A

Report date: 2025/01/26 18:58:17
NME

Base Information

Drug NameBLI-1007
Drug Alias NameBLI-1007
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiolite Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiolite Inc
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A